Skip to main content

We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.news

Published loading...Updated

Re: Risk of Hair Loss Associated with Glucagon-Like Peptide-1 Receptor Agonists in Adults with Type 2 Diabetes: Target Trial Emulation

Doctors say the shedding is usually telogen effluvium and often eases after 3 to 6 months, though nutrition and rapid weight loss can worsen it.

Summary by The BMJ
Open the article to view the coverage from The BMJ

9 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Metro News broke the news in London, United Kingdom on Tuesday, August 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal